An aspirin a day can cut cancer risk in over 40sApril 29th, 2009 - 12:23 pm ICT by ANI
London, Apr 29 (ANI): A daily dose of aspirin in your 40s could cut the risk of developing cancer later in life, a new study claims.
A study published in the Lancet Oncology suggests taking aspirin at any age before cancer begins to develop - and for at least ten years - would maximise the drug’s potential to prevent the fatal disease.
Researchers believe the drug blocks the effects of the COX enzymes - proteins involved in inflammation and found at unusually high levels in several types of cancer, reports The Daily Express.
Study author Professor Jack Cuzick of the Cancer Research UK Centre for Epidemiology at Queen Mary, University of London, said: “Taking aspirin regularly in your mid-40s could maximise the effect this drug has on preventing cancer.
“Taking aspirin at this age, which is about the time pre-cancerous lesions usually begin to develop, may be the best time to stop the disease progressing.”(ANI)
- Taking aspirin daily 'cuts prostate cancer risk by 30pc' - Aug 12, 2010
- Eating strawberries may help prevent esophageal cancer - Apr 07, 2011
- Aspirin advised for everyone over 45 to keep heart disease, cancer at bay - Nov 24, 2010
- Preventive use of breast cancer drugs urged - Mar 28, 2011
- Aspirin may cut bowel cancer risk - Oct 22, 2010
- Aspirin cuts cancer risk - Mar 21, 2012
- Daily aspirin cuts bowel cancer death risk - Apr 26, 2012
- Aspirin could compromise effectiveness of vaccines - Dec 02, 2009
- Widely used arthritis pill shows promise against skin cancer - Dec 03, 2010
- Aspirin reduces prostate cancer risk by 30 percent - Aug 13, 2010
- Estrogen may promote spread of precancerous cells in oral cavity - Jan 04, 2011
- Aspirin may cut breast cancer patients' death risk - Feb 17, 2010
- Aspirin lowers risk of cancer mortality - Aug 12, 2012
- Everyone over 45 should take aspirin daily: Study - Nov 24, 2010
- How omega-3 fatty acids keep blindness at bay - Feb 10, 2011
Tags: aspirin, best time, cancer research uk, cancer risk, cancerous lesions, daily dose, disease researchers, drug blocks, enzymes, epidemiology, inflammation, lancet oncology, mid 40s, oncology, professor jack, queen mary university, queen mary university of london, study author, types of cancer, university of london